Your browser doesn't support javascript.
loading
Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II study.
Miglietta, L; Canobbio, L; Granetto, C; Vannozzi, M O; Esposito, M; Boccardo, F.
Affiliation
  • Miglietta L; Department of Medical Oncology II, National Institute for Cancer Research, Genoa, Italy.
J Cancer Res Clin Oncol ; 123(7): 407-10, 1997.
Article in En | MEDLINE | ID: mdl-9260594
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Suramin / Epirubicin / Adenocarcinoma Type of study: Risk_factors_studies Limits: Humans / Male Language: En Journal: J Cancer Res Clin Oncol Year: 1997 Document type: Article Affiliation country: Italia Country of publication: Alemania
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Suramin / Epirubicin / Adenocarcinoma Type of study: Risk_factors_studies Limits: Humans / Male Language: En Journal: J Cancer Res Clin Oncol Year: 1997 Document type: Article Affiliation country: Italia Country of publication: Alemania